Companies
In Brief This Week: Cepheid, Biocartis, Sight Diagnostics, Fluidigm, Co-Diagnostics, and More
News items for in vitro diagnostics industry for the week of Jan. 10, 2022.
Quanterix Projects Q4 2021 Revenues of $29M to $31M
The company projected full year 2021 revenues of $109 million to $111 million, up from $86.4 million in 2020.
JP Morgan Healthcare Conference Day 3: Quest Diagnostics, Exact Sciences, Quidel, More
Highlights of the third day included Quest's view on its information and services business and Quidel's take on the proposed Ortho Clinical buy.
Accelerate Diagnostics CEO Lays Out Plans at JP Morgan Healthcare Conference
The company said that it contracted 16 Pheno instruments with new US customers during Q4 and ended 2021 with 81 instruments in its US backlog.
Interpace Commences $30M Rights Offering
The company said the offering will help raise capital while allowing existing shareholders to maintain their proportional ownership in the company.
Jan 11, 2022
Freenome Nets $290M Investment From Roche
Jan 11, 2022
LumiraDx Gets CE Mark for C-Reactive Protein Test
Jan 10, 2022
Jan 10, 2022